Related Experiment Video
Updated: Jul 29, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
[Prognosis after late versus early nonfatal myocardial infarction]
A Sajadieh1, J F Hansen, L S Mortensen
1H:S Bispebjerg Hospital, kardiologisk klinik, og UNI-C Aarhus.
Insights
Recurrent myocardial infarction (RMIs) occurring later than one year after an initial heart attack carry a prognosis as grave as those within the first year. This study found no significant difference in mortality rates, highlighting the consistent risk of recurrent events.
Area of Science:
- Cardiology
- Clinical Medicine
- Public Health
Background:
- Nonfatal recurrent myocardial infarction (RNMI) is a significant predictor of patient outcomes.
- Existing research primarily focuses on RNMI within the first year post-index infarction.
- Prognosis following late RNMI remains under-investigated.
Purpose of the Study:
- To investigate the prognosis of nonfatal recurrent myocardial infarction (RNMI) based on the timing of its occurrence after an index myocardial infarction.
- To compare the mortality rates associated with early (first year) versus late (second to fourth year) RNMI.
Main Methods:
- A cohort of 3,867 unselected patients under 76 years with acute myocardial infarction was studied.
- Kaplan-Meier method was used for mortality estimation.
- Tarone-Ware test was employed to evaluate differences in mortality rates.
Main Results:
- 13.6% of patients experienced RNMI within the first year, with a 23.7% one-year mortality rate.
- 5.4%, 4.2%, and 3.8% experienced RNMI in the second, third, and fourth years, respectively.
- One-year mortality rates for late RNMI were 24.1% (year 2), 17.5% (year 3), and 22.8% (year 4).
- No statistically significant difference in mortality rates or standardized mortality ratios was found between early and late RNMI groups (p = 0.12).
Conclusions:
- Late and early nonfatal recurrent myocardial infarctions (RNMIs) share a similarly grave prognosis.
- The timing of RNMI after an index infarction does not significantly alter the associated mortality risk.
- Patients experiencing RNMI, regardless of timing, face a substantial and consistent risk of death.
Abstract:
Many recent studies have identified nonfatal recurrent myocardial infarction (RNMI) as the most significant predictor for later outcome. Almost all of these studies have been based on the studies of RNMI in the first year after the index infarction. The prognosis after late RNMI has not been studied properly. In 3,867 nonselected patients below 76 years of age with an acute myocardial infarction we studied the prognosis after a first RNMI depending on the year of its occurrence after the index infarction. Mortality was estimated by the method of Kaplan-Meier and the differences were evaluated by means of the Tarone-Ware test. Four hundred and ninety-three (13.6%) patients had a first RNMI in the first, 151 (5.4%) in the second, 105 (4.2%) in the third, and 71 (3.8%) in the fourth year after the index infarction (group 1-4). One-year mortality rate after RNMI was 23.7% in the first group, 24.1% in the second, 17.5% in the third, and 22.8 in the fourth group. When all the groups were compared with each other no significant difference was found between the mortality rates (p = 0.12) or Standardised Mortality Rates. We concluded that late and early RNMIs have almost the same grave prognosis.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis III: Medical Management
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Heart Failure IV: Classification and Diagnostic Evaluation

